Your browser is no longer supported. Please, upgrade your browser.
Asensus Surgical, Inc.
Index- P/E- EPS (ttm)-0.64 Insider Own0.20% Shs Outstand232.82M Perf Week7.69%
Market Cap678.04M Forward P/E- EPS next Y-0.25 Insider Trans-41.42% Shs Float228.56M Perf Month92.81%
Income-60.40M PEG- EPS next Q-0.06 Inst Own18.80% Short Float4.89% Perf Quarter-22.22%
Sales4.70M P/S144.26 EPS this Y90.20% Inst Trans111.02% Short Ratio0.95 Perf Half Y430.92%
Book/sh1.00 P/B3.22 EPS next Y7.40% ROA-52.70% Target Price4.00 Perf Year376.12%
Cash/sh- P/C- EPS next 5Y- ROE-62.00% 52W Range0.30 - 6.95 Perf YTD415.20%
Dividend- P/FCF- EPS past 5Y35.60% ROI-91.40% 52W High-53.67% Beta1.53
Dividend %- Quick Ratio18.00 Sales past 5Y- Gross Margin-40.40% 52W Low973.33% ATR0.34
Employees128 Current Ratio19.20 Sales Q/Q250.00% Oper. Margin- RSI (14)63.19 Volatility14.62% 13.76%
OptionableYes Debt/Eq0.01 EPS Q/Q85.60% Profit Margin- Rel Volume0.73 Prev Close3.24
ShortableYes LT Debt/Eq0.00 EarningsMay 11 AMC Payout- Avg Volume11.79M Price3.22
Recom2.50 SMA2033.39% SMA5040.45% SMA20073.55% Volume8,639,233 Change-0.62%
May-26-21Initiated H.C. Wainwright Buy $4
Jun-08-21 06:55AM  
Jun-03-21 03:03PM  
May-28-21 08:00AM  
May-20-21 06:55AM  
May-17-21 09:00AM  
May-13-21 08:27AM  
May-12-21 09:00AM  
May-11-21 04:05PM  
May-10-21 07:45AM  
Apr-29-21 06:55AM  
Mar-11-21 04:05PM  
Mar-05-21 06:55AM  
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fernando Anthony C. J.President and CEOJun 09Option Exercise0.82183,338150,337620,502Jun 10 08:40 PM
Fernando Anthony C. J.President and CEOJun 09Sale3.10295,682916,613324,820Jun 10 08:40 PM
Fernando Anthony C. J.President and CEOJun 08Option Exercise0.00550,0000685,126Jun 10 08:40 PM
Fernando Anthony C. J.President and CEOJun 08Sale3.512,1127,413437,164Jun 10 08:40 PM